Daniel Uusitalo is an investor at 4impact capital, a venture fund backing Pre-seed to Series A startups in Europe that solve problems relating to Planet & People.

Amatera, a Paris-based biotechnology company, announced the closing of its latest funding round of €6 million in equity. The round was co-led by Demea Sustainable Investment (ex-Demeter) and Oyster Bay Venture Capital, with participation from existing investors - PINC, Mudcake, and Exceptional Ventures.

Antiverse, UK-based biotech developing AI-designed therapeutic antibodies for undruggable disease targets, closed a Series A round of $9.3 million. The round was led by Soulmates Ventures with participation from Innovation Investment Capital, DOMiNO Ventures and existing investors DBW, Kadmos Capital and i&i Biotech Fund.

Yujia Du helps climate leaders drive meaningful impact authentically through coaching.

German-based healthtech company Oska Health announced an €11 million seed funding round, led by Capricorn Partners and SwissHealth Ventures.

nyra Health, developer of an AI-powered platform for neurological therapy, has successfully closed a €20 million Series A funding round.

The Gates Foundation has awarded a $5 million grant to Axmed, a Swiss health-tech startup modernizing how essential medicines are procured across emerging markets.